CEO's Oversight Doesn't Merit $1M Tax Penalty, Judge Says
A Pennsylvania federal judge on Wednesday sided with a pharmaceutical CEO challenging a nearly $1 million tax penalty, ruling after a bench trial that while the executive may have been negligent...To view the full article, register now.
Already a subscriber? Click here to view full article